12 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp07411 | Si1 | (KLAKLAK)2 | Synthetic | Membrane disruption induces cancer apoptosis | MTT assay | MCF-7 | Breast Cancer | IC50 = 124.1 ± 8.12 µM |
| dbacp07412 | Si1 | (KLAKLAK)2 | Synthetic | Membrane disruption induces cancer apoptosis | MTT assay | MDA-MB-231 | Breast Cancer | IC50 = 746.5 ± 7.6 µM |
| dbacp07413 | Si3 | KL(Beta-A)KL(Beta-A)AK | Synthetic | Membrane disruption induces cancer apoptosis | MTT assay | MCF-7 | Breast Cancer | IC50 = 176.3 ± 4.66 µM |
| dbacp07414 | Si2 | KL(Beta-A)KL(Beta-A)K | Synthetic | Membrane disruption induces cancer apoptosis | MTT assay | MCF-7 | Breast Cancer | IC50 = 662.9 ± 20.02 µM |
| dbacp07415 | Si2 | KL(Beta-A)KL(Beta-A)K | Synthetic | Membrane disruption induces cancer apoptosis | MTT assay | MDA-MB-231 | Breast Cancer | IC50 = 840 ± 21.18 µM |
| dbacp07416 | Si11 | KL(Beta-A)KL(Beta-A)K | Synthetic | Membrane disruption induces cancer apoptosis | MTT assay | MDA-MB-231 | Breast Cancer | IC50 = 1087 ± 70.71 µM |
| dbacp07417 | Si11 | KL(Beta-A)KLAK | Synthetic | Membrane disruption induces cancer apoptosis | MTT assay | MCF-7 | Breast Cancer | IC50 = 228.8 ± 7.18 µM |
| dbacp07418 | Si13 | KnLAKnLAK | Synthetic | Membrane disruption induces cancer apoptosis | MTT assay | MCF-7 | Breast Cancer | IC50 = 1704 ± 112 µM |
| dbacp07419 | Si14 | KnLAKnLAK | Synthetic | Membrane disruption induces cancer apoptosis | MTT assay | MCF-7 | Breast Cancer | IC50 = 593.3 ± 60.3 µM |
| dbacp07420 | Si14 | KnLAKnLAK | Synthetic | Membrane disruption induces cancer apoptosis | MTT assay | MDA-MB-231 | Breast Cancer | IC50 = 1049 ± 49.77 µM |
| dbacp07421 | Si15 | KnLAKnLAK | Synthetic | Membrane disruption induces cancer apoptosis | MTT assay | MCF-7 | Breast Cancer | IC50 = 140.3 ± 7.12 µM |
| dbacp07422 | Si15 | KnLAKnLAK | Synthetic | Membrane disruption induces cancer apoptosis | MTT assay | MDA-MB-231 | Breast Cancer | IC50 = 346.3 ± 7.91 µM |